These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17367310)

  • 1. Type 1 diabetes and prolonged fasting.
    Reiter J; Wexler ID; Shehadeh N; Tzur A; Zangen D
    Diabet Med; 2007 Apr; 24(4):436-9. PubMed ID: 17367310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A; Zantout MS; Azar ST
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescents on basal-bolus insulin can fast during Ramadan.
    Al-Khawari M; Al-Ruwayeh A; Al-Doub K; Allgrove J
    Pediatr Diabetes; 2010 Mar; 11(2):96-100. PubMed ID: 19947956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
    Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
    Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education.
    Ahmedani MY; Haque MS; Basit A; Fawwad A; Alvi SF
    Diabet Med; 2012 Jun; 29(6):709-15. PubMed ID: 22587405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The basal insulin dose; a lesson from prolonged fasting in young individuals with type 1 diabetes.
    Strich D; Teomim R; Gillis D
    Pediatr Diabetes; 2015 Dec; 16(8):629-33. PubMed ID: 25040034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and associations of psychological distress in young adults with Type 1 diabetes.
    Hislop AL; Fegan PG; Schlaeppi MJ; Duck M; Yeap BB
    Diabet Med; 2008 Jan; 25(1):91-6. PubMed ID: 18199136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
    Knerr I; Hofer SE; Holterhus PM; Näke A; Rosenbauer J; Weitzel D; Wolf J; Holl RW
    Diabet Med; 2007 Dec; 24(12):1478-81. PubMed ID: 17971184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC; Sutton AJ
    Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
    Yeap BB
    Aust Fam Physician; 2007 Jul; 36(7):549-53. PubMed ID: 17619673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y; Guo XH; Vaz JA;
    Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.